2000
DOI: 10.1016/s0920-9964(00)91061-2
|View full text |Cite
|
Sign up to set email alerts
|

Antipsychotic treatment and changes in health related quality of life in patients with schizophrenia using EQ-5D

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
1

Year Published

2001
2001
2014
2014

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 0 publications
0
3
1
Order By: Relevance
“…The QoL score was lower in the group with possible PTSD (mean score 39.6 mm), than what has been reported for many other diseases. One group of patients with small cell lung cancer scored on average 58 mm (20), patients with rheumatoid arthritis scored 56 mm (21), multiple sclerosis 49 mm (22), and patients with schizophrenia scored on average 49 mm (23). Only patients with late stage amyotrophic lateral sclerosis (mean score 37 mm) (24) scored lower on self-rated QoL than respondents did in our study.…”
Section: Discussioncontrasting
confidence: 50%
“…The QoL score was lower in the group with possible PTSD (mean score 39.6 mm), than what has been reported for many other diseases. One group of patients with small cell lung cancer scored on average 58 mm (20), patients with rheumatoid arthritis scored 56 mm (21), multiple sclerosis 49 mm (22), and patients with schizophrenia scored on average 49 mm (23). Only patients with late stage amyotrophic lateral sclerosis (mean score 37 mm) (24) scored lower on self-rated QoL than respondents did in our study.…”
Section: Discussioncontrasting
confidence: 50%
“…This notion is supported by the fact that a simple non-weighted sum-score of dimensions, more adequately signifies the apparent changes. Also in a study of Badia et al [29] on antipsychotic treatment and changes in QoL in schizophrenic patients, these notions are more or less supported. In their study the domains 'daily activities' and 'anxiety/depression' improved in a rather similar way (from an average of 82 and 78% of patients with problems in both domains to 55 and 46% respectively).…”
Section: Discussionmentioning
confidence: 97%
“…Previous published results from the EFESO study have shown that olanzapine-treated patients have achieved superior outcomes compared to patients treated with risperidone or haloperidol [31,33,34]. Statistically significant findings favouring olanzapine-treated patients compared to risperidone- and/or haloperidol-treated patients have included the proportion of patients who experienced at least one adverse event, the percentage of patients who developed EPS, and the proportion of responders at month six (olanzapine compared to risperidone).…”
Section: Discussionmentioning
confidence: 99%